Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9487509 Heterocyclic compound

Patent 9487509 was granted and assigned to Takeda Pharmaceutical Company on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Takeda Pharmaceutical Company

Current Assignee

Takeda Pharmaceutical Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9487509

Patent Inventor Names

Masahiro Kamaura0

Shizuo Kasai0

Tomohiro Kaku0

Date of Patent

November 8, 2016

Patent Application Number

14055585

Date Filed

October 16, 2013

Patent Citations Received

‌

US Patent 11951100 Formulations of RBP4 inhibitors and methods of use

‌

US Patent 12016853 Methods of treating RBP4 related diseases with triazolopyridines

‌

US Patent 11980614 Methods of treating RBP4 related diseases with triazolopyridines

Patent Primary Examiner

‌

Sun Jae Yoo

Patent abstract

The present invention relates to

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9487509 Heterocyclic compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API